RIAS A/S (CPH: RIAS.B)
Denmark
· Delayed Price · Currency is DKK 660.00
+25.00 (3.94%)
Dec 20, 2024, 3:11 PM CET
RIAS A/S Revenue
In the fiscal year ending September 30, 2024, RIAS A/S had annual revenue of 319.09M DKK with 1.90% growth. RIAS A/S had revenue of 182.58M in the half year ending September 30, 2024, a decrease of -2.49%.
Revenue
319.09M
Revenue Growth
+1.90%
P/S Ratio
0.48
Revenue / Employee
3.04M
Employees
106
Market Cap
152.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 319.09M | 5.95M | 1.90% |
| Sep 30, 2023 | 313.14M | -25.58M | -7.55% |
| Sep 30, 2022 | 338.73M | 30.26M | 9.81% |
| Sep 30, 2021 | 308.47M | 14.10M | 4.79% |
| Sep 30, 2020 | 294.37M | 9.00M | 3.15% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novozymes A/S | 22.71B |
| SP Group A/S | 2.85B |
| H+H International A/S | 2.70B |
| Flügger group A/S | 2.25B |
| Scandinavian Investment Group A/S | 28.00M |
| Hove A/S | 176.31M |
| Novo Nordisk A/S | 270.58B |
| DSV A/S | 160.12B |